Randomised, pragmatic, waitlist controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: study protocol.

ABSTRACT:

Introduction

Chronic, non-cancer pain impacts approximately 50 million adults in the USA (20%), approximately 25% of whom receive chronic prescription opioids for pain despite limited empirical efficacy data and strong dose-related risk for opioid use disorder and opioid overdose. Also despite lack of efficacy data, there are many reports of people using cannabis products to manage chronic pain and replace or reduce chronic opioids. Here we describe the protocol for a randomised trial of the effect of cannabis, when added to a behavioural pain management and prescription opioid taper support programme, on opioid utilisation, pain intensity and pain interference.

Methods

This is a pragmatic, single-blind, randomised, wait-list controlled trial that aims to enrol 250 adults ta

SUBMITTER: Jashinski J 

PROVIDER: S-EPMC9185656 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature